hVIVO plc (LON:HVO)
8.30p+2.47%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Unique challenge-trial moat holds firm despite cash burn; new contracts signal early recovery.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About hVIVO plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including …
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- £55.8M
Recent dividends
- 15 May 20250.20p
- 18 Apr 20240.20p
- 4 May 20230.45p(special)
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on hVIVO plc and 1,600+ UK and US stocks.
Start free